U.S., Aug. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07771140) titled 'A Phase I Clinical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subjects With Chronic Hepatitis B' on Aug. 06.
Brief Summary: To evaluate the safety, efficacy, pharmacokinetics and immunogenicity of single and multiple doses of HECN30227 Injection in healthy volunteers and patients with chronic hepatitis B
Study Start Date: Dec. 02, 2025
Study Type: INTERVENTIONAL
Condition:
HBV Infection
Intervention:
DRUG: HECN30227 injection(SAD)
single subcutaneous administrations
DRUG: Placebo(MAD)
0.9% Sodium Chloride Injection
DRUG: Placebo(SAD)
0.9% Sodium Chloride Injection
DRUG: HECN30227 injection (MAD)
multi...